Cholic Acid: Clinical Trials

7 trials of Cholic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 terminated. 3 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2
Not applicable1Terminated 1
Phase 11Completed 1

Follow Cholic Acid: new trials by email Literature Review of Cholic Acid trials Research Report on Cholic Acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smith-Lemli-Opitz Syndrome and Cholic Acid
Cholic Acid - Smith-Lemli-Opitz Syndrome
Phase 1 / Phase 2CompletedUniversity of Nebraska122021-03-272024-04-30
The REPLACE Registry for CholbamĀ® (Cholic Acid)
Cholbam - Bile Acid Synthesis Disorders
Active not recruitingMirum Pharmaceuticals, Inc.552017-07-102026-07-31
Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis
Cholic acid - Inborn Errors of Bile Acid Synthesis
Phase 3CompletedMirum Pharmaceuticals, Inc.162010-04-012023-10-03
Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis
Cholic Acid - Bile Acid Synthesis Defect
Phase 3CompletedMirum Pharmaceuticals, Inc.532010-01-012023-10-03
Cholic Acid for Hepatic Steatosis in Lipodystrophy
Cholic Acid - Hepatic Steatosis
Phase 2CompletedUniversity of Texas Southwestern Medical Center182006-04-012025-08-06
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
Cholic Acids - Infantile Refsum's Disease, Zellweger Syndrome
Phase 3CompletedMirum Pharmaceuticals, Inc.851992-01-012023-10-03
Study of Bile Acids in Patients With Peroxisomal Disorders
chenodeoxycholic acid, cholic acid, ursodiol - Infantile Refsum's Disease, Zellweger Syndrome
Not applicableTerminatedUniversity of Cincinnati252015-03-25

Conditions studied

Peroxisomal Disorders (3)  ·  Zellweger Syndrome (3)  ·  Adrenoleukodystrophy (2)  ·  Refsum Disease, Infantile (2)  ·  Cholestasis (1)  ·  Fatty Liver (1)  ·  Lipodystrophy (1)  ·  Liver Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Pseudo-Zellweger syndrome (1)  ·  Rare Diseases (1)  ·  Smith-Lemli-Opitz Syndrome (1)  ·  Sphingolipidoses (1)

Sponsors

Mirum Pharmaceuticals, Inc. (4)  ·  University of Cincinnati (1)  ·  University of Nebraska (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (6)

Top investigators

James E Heubi, MD (2)  ·  Kenneth Setchell, PhD (2)  ·  Abhimanyu Garg, M.D. (1)  ·  Ellen R Elias, MD (1)  ·  James Heubi, MD (1)  ·  Kenneth Setchell (1)  ·  Sagar A Vaidya, MD, PhD (1)  ·  William B Rizzo, MD (1)

Results publications

PMID 23447519, PMID 28644367, PMID 31899729